Vanderbilt-Ingram Cancer Center, Vanderbilt University — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center, Vanderbilt University is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center, Vanderbilt University has participated in 3 clinical trials.

Therapeutic areas: Leukemia, Lymphoma, Acute Myeloid Leukemia (AML).

Sponsors: Virginia Commonwealth University, Karyopharm Therapeutics Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center, Vanderbilt University?

Vanderbilt-Ingram Cancer Center, Vanderbilt University has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center, Vanderbilt University conducted?

Vanderbilt-Ingram Cancer Center, Vanderbilt University has 3 clinical trials on record. Their work covers Leukemia, Lymphoma, Acute Myeloid Leukemia (AML).

Is Vanderbilt-Ingram Cancer Center, Vanderbilt University accredited by Crixeo Clinical Trials?

Vanderbilt-Ingram Cancer Center, Vanderbilt University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center, Vanderbilt University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.